IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $1.20 billion. The enterprise value is $1.15 billion.
| Market Cap | 1.20B |
| Enterprise Value | 1.15B |
Important Dates
The last earnings date was Monday, November 3, 2025, before market open.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | Nov 14, 2025 |
Share Statistics
IRMD has 12.72 million shares outstanding. The number of shares has increased by 0.68% in one year.
| Current Share Class | 12.72M |
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | +0.68% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 36.20% |
| Owned by Institutions (%) | 49.09% |
| Float | 7.35M |
Valuation Ratios
The trailing PE ratio is 57.32 and the forward PE ratio is 52.54.
| PE Ratio | 57.32 |
| Forward PE | 52.54 |
| PS Ratio | 14.93 |
| Forward PS | 13.41 |
| PB Ratio | 12.23 |
| P/TBV Ratio | 12.67 |
| P/FCF Ratio | 81.56 |
| P/OCF Ratio | 48.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 44.38, with an EV/FCF ratio of 77.73.
| EV / Earnings | 54.12 |
| EV / Sales | 14.24 |
| EV / EBITDA | 44.38 |
| EV / EBIT | 46.13 |
| EV / FCF | 77.73 |
Financial Position
The company has a current ratio of 6.64
| Current Ratio | 6.64 |
| Quick Ratio | 5.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.31% and return on invested capital (ROIC) is 17.07%.
| Return on Equity (ROE) | 23.31% |
| Return on Assets (ROA) | 14.87% |
| Return on Invested Capital (ROIC) | 17.07% |
| Return on Capital Employed (ROCE) | 24.38% |
| Revenue Per Employee | $503,195 |
| Profits Per Employee | $132,405 |
| Employee Count | 160 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 1.61 |
Taxes
In the past 12 months, IRMD has paid $5.73 million in taxes.
| Income Tax | 5.73M |
| Effective Tax Rate | 21.29% |
Stock Price Statistics
The stock price has increased by +72.83% in the last 52 weeks. The beta is 1.08, so IRMD's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +72.83% |
| 50-Day Moving Average | 81.13 |
| 200-Day Moving Average | 64.70 |
| Relative Strength Index (RSI) | 74.87 |
| Average Volume (20 Days) | 67,612 |
Short Selling Information
The latest short interest is 269,756, so 2.12% of the outstanding shares have been sold short.
| Short Interest | 269,756 |
| Short Previous Month | 200,076 |
| Short % of Shares Out | 2.12% |
| Short % of Float | 3.67% |
| Short Ratio (days to cover) | 3.65 |
Income Statement
In the last 12 months, IRMD had revenue of $80.51 million and earned $21.18 million in profits. Earnings per share was $1.65.
| Revenue | 80.51M |
| Gross Profit | 62.05M |
| Operating Income | 24.85M |
| Pretax Income | 26.91M |
| Net Income | 21.18M |
| EBITDA | 25.83M |
| EBIT | 24.85M |
| Earnings Per Share (EPS) | $1.65 |
Balance Sheet
The company has $56.53 million in cash and n/a in debt, giving a net cash position of $56.53 million or $4.44 per share.
| Cash & Cash Equivalents | 56.53M |
| Total Debt | n/a |
| Net Cash | 56.53M |
| Net Cash Per Share | $4.44 |
| Equity (Book Value) | 98.35M |
| Book Value Per Share | 7.73 |
| Working Capital | 72.12M |
Cash Flow
In the last 12 months, operating cash flow was $25.01 million and capital expenditures -$10.26 million, giving a free cash flow of $14.75 million.
| Operating Cash Flow | 25.01M |
| Capital Expenditures | -10.26M |
| Free Cash Flow | 14.75M |
| FCF Per Share | $1.16 |
Margins
Gross margin is 77.07%, with operating and profit margins of 30.87% and 26.31%.
| Gross Margin | 77.07% |
| Operating Margin | 30.87% |
| Pretax Margin | 33.43% |
| Profit Margin | 26.31% |
| EBITDA Margin | 32.09% |
| EBIT Margin | 30.87% |
| FCF Margin | 18.32% |
Dividends & Yields
This stock pays an annual dividend of $0.68, which amounts to a dividend yield of 0.72%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 0.72% |
| Dividend Growth (YoY) | 51.11% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.22% |
| Buyback Yield | -0.68% |
| Shareholder Yield | 0.04% |
| Earnings Yield | 1.76% |
| FCF Yield | 1.23% |
Analyst Forecast
The average price target for IRMD is $72.00, which is -23.87% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.00 |
| Price Target Difference | -23.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 29.79 and a Piotroski F-Score of 4.
| Altman Z-Score | 29.79 |
| Piotroski F-Score | 4 |